Target intelligence / Profile preview

Elongation factor G (EF-G) (EF-G)

Target
EF-G
Molecular classification
GTPase, Translation factor, Enzyme
01

Overview

Elongation factor G (EF-G), encoded by the fusA gene, is a vital GTPase that facilitates the translocation of mRNA and tRNAs within the bacterial ribosome during the elongation phase of protein synthesis [1, 8]. By hydrolyzing GTP, EF-G provides the energy necessary to move the ribosome one codon forward, ensuring the accurate and rapid assembly of polypeptides [1, 6]. Beyond elongation, EF-G is also essential for ribosome recycling, collaborating with the ribosome recycling factor (RRF) to dissociate the ribosomal subunits after protein release [17, 19]. Due to its indispensable role in bacterial growth, EF-G is a major target for antibiotics, most notably fusidic acid, which traps the factor on the ribosome in a GDP-bound state [4, 7]. This immobilization halts protein production, leading to bacteriostatic or bactericidal effects [4, 11]. Resistance to EF-G inhibitors typically involves mutations in the fusA gene, which can alter drug binding or factor kinetics, presenting a challenge in treating infections like those caused by Staphylococcus aureus [4, 7].

Other names
TranslocasefusA gene productPeptide elongation factor GEF-G1EF-G2
02

Mechanism of action

Inhibition of protein synthesis by stabilizing the EF-G-GDP-ribosome complex, preventing translocation and factor dissociation (e.g., fusidic acid), or by interfering with EF-G binding to the GTPase-associated center (e.g., thiopeptides).

03

Biological functions

Protein synthesismRNA-tRNA translocationRibosome recycling
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistance developmentPotential cross-reactivity with mitochondrial elongation factors
06

Interacting drugs

Fusidic acid

4 more in the full profile.

07

Biomarkers

fusA gene mutations

Beyond the preview

Go deeper on Elongation factor G (EF-G) (EF-G).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongation factor G (EF-G) (EF-G).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call